Abstract
Myostatin (MSTN) is a negative regulator of skeletal muscle development. This study explored using RNA interference (RNAi) to generate transgenic sheep with a "double-muscle" phenotype. By combining shRNA-based knockdown with somatic cell nuclear transfer (SCNT), researchers produced three live transgenic lambs. Molecular analysis confirmed the integration and expression of the shRNA, leading to significant inhibition of MSTN protein. These transgenic sheep exhibited faster weight gain and larger myofiber diameters compared to controls, demonstrating a promising approach for enhancing livestock productivity.
Introduction
In livestock production, enhancing muscle growth is a primary goal. Myostatin (MSTN) acts as a natural "brake" on muscle development; its absence in certain cattle breeds results in extreme muscularity. However, traditional gene knockout in sheep is difficult due to the lack of stable embryonic stem cell lines. This study investigates whether RNA interference (RNAi)—which reduces rather than eliminates gene expression—can effectively promote muscle growth in sheep while avoiding the potential health complications associated with complete gene knockouts.
Methods and Vector Design
The researchers developed a multi-step bioengineering pipeline. First, they designed a plasmid vector containing a short hairpin RNA (shRNA) expression cassette specifically targeting sheep MSTN mRNA.
Sheep fibroblast cells were transfected with this vector, and stable clones were selected. These engineered nuclei were then used in somatic cell nuclear transfer (SCNT) to create cloned embryos, which were transferred into recipient ewes. Out of 429 embryos, five lambs were born, with three (M17, M18, and M23) surviving for long-term study.
Molecular Validation and Key Results
The success of the genetic modification was verified through several molecular assays. PCR confirmed the integration of the transgene, while RNase protection assays (RPA) demonstrated that the shRNA was actively expressed in the muscle tissues of the transgenic lambs.
The most significant finding was the reduction of MSTN protein levels. In lamb M17, MSTN expression was inhibited by 61.12% compared to controls. This molecular knockdown translated into a clear physical phenotype:
- Weight Gain: At three months, M17 weighed 25.42 kg, significantly higher than the control average of 21.22 kg. M17’s daily weight gain was 0.23 kg/day, compared to 0.18 kg/day for controls.
- Muscle Histology: Histological analysis revealed that the mean myofiber diameter in M17 was 58 µm, compared to 47 µm in control sheep, indicating that muscle growth was driven primarily by hypertrophy (increased fiber size).
Discussion and Insights
The study revealed that knocking down MSTN triggers a regulatory cascade, upregulating myogenic factors like MyoD and Myogenin. Interestingly, phenotypic variability was observed; despite being derived from the same cell line, M17 showed much stronger suppression than M18. This suggests that the genomic location of the transgene insertion ("position effects") or epigenetic factors during the cloning process play a critical role in the final outcome.
Limitations and Future Outlook
While successful, the study notes several challenges. The cloning efficiency remains low (1.2%), and the small sample size limits broad statistical conclusions. Furthermore, the long-term health, meat quality, and fertility of these transgenic animals require further investigation. Future efforts may utilize more precise gene-editing tools like CRISPR/Cas9 to achieve similar results without the need for antibiotic resistance markers.
Summary updated